VNDA logo

VNDAVanda Pharmaceuticals Inc

$6.10
$0.07
(1.16%)
Today
Closed $6.10
$0.01
(0.16%)
After Hours
Updated: 07:11 PM EDT
EarningsJul 29
Mkt Cap$362.62M
Vol991,967.00

About

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
533

Frequently Asked Questions

What is Market Cap of Vanda Pharmaceuticals Inc?
What is the 52-week high for Vanda Pharmaceuticals Inc?
What is the 52-week low for Vanda Pharmaceuticals Inc?
What is Vanda Pharmaceuticals Inc stock price today?
What was Vanda Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Vanda Pharmaceuticals Inc?
What is the Price-to-Book ratio of Vanda Pharmaceuticals Inc?
What is the 50-day moving average of Vanda Pharmaceuticals Inc?
How many employees does Vanda Pharmaceuticals Inc have?

Advertisement|Remove ads.